Benjamin J. Hindson - 22 Nov 2022 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role
President and Chief Scientific Officer, Director
Signature
/s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson
Issuer symbol
TXG
Transactions as of
22 Nov 2022
Net transactions value
-$80,434
Form type
4
Filing time
23 Nov 2022, 16:02:17 UTC
Previous filing
16 Sep 2022
Next filing
16 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TXG Class A Common Stock Sale $12,230 -359 -0.16% $34.07 219,715 22 Nov 2022 Direct F1
transaction TXG Class A Common Stock Sale $31,172 -915 -0.42% $34.07 218,800 22 Nov 2022 Direct F1
transaction TXG Class A Common Stock Sale $37,032 -1,087 -0.5% $34.07 217,713 22 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

President and Chief Scientific Officer